Joel Michael Maryles Chemomab Therapeutics Ltd. (CMMB) insider trading activity

CMMB Quotes by TradingView

Joel Michael Maryles is Director of Chemomab Therapeutics Ltd.. Currently has a direct ownership of 1,433 shares of CMMB, which is worth approximately $2,407. The most recent transaction as insider was on May 24, 2022, when has been sold 433 shares (American Depositary Shares) at a price of $2.83 per share, resulting in proceeds of $1,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.43K
0% 3M change
0% 12M change
Total Value Held $2,407

Joel Michael Maryles Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2022
BUY
Open market or private purchase
$1,225 $2.83 p/Share
433 Added 23.2%
1,433 American Depositary Sh...
Mar 18 2022
BUY
Open market or private purchase
$4,340 $4.34 p/Share
1,000 Added 50.0%
1,000 American Depositary Sh...
JMM

Joel Michael Maryles

Director
Hashmonaim, L3

Track Institutional and Insider Activities on CMMB

Follow Chemomab Therapeutics Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMMB shares.

Notify only if

Insider Trading

Get notified when an Chemomab Therapeutics Ltd. insider buys or sells CMMB shares.

Notify only if

News

Receive news related to Chemomab Therapeutics Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CMMB